Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Federal officials said it would take until January, or late November at the earliest, to make enough vaccine to protect all Americans from a possible epidemic of swine flu. And beyond the United States and a few other countries that also make vaccines, some experts said it could take years …
Fresh efforts and funding to tackle malaria in recent years have brought the goal of eradicating the deadly disease within sight, health experts said on Friday. Wiping out malaria worldwide could take decades but many countries where it is endemic are on the brink of eliminating the disease, which infects …
While confirmed cases of swine flu increased only slightly on Monday, the World Health Organization voted to raise its global pandemic flu alert level, but at the same time it recommended that borders not be closed nor travel bans imposed. The W.H.O.
New Delhi: As countries around the world reach out for the panic button over reports of swine influenza (H1N1 virus) striking human populace in Mexico, domestic companies like Roche, Cipla and Hetero Drugs are gearing up to supply the bird flu drug, oseltamivir, to the Indian and overseas markets in …
PAWAN BALI The spread of Swine flu is likely to boost the sales of companies like Cipla, which can provide drugs and vaccines for this deadly disease. Ms Sarabjit Kaur Nagra, pharma analyst with Angel Broking said that Cipla and Ranbaxy are the two Indian companies, which can provide drugs …
Without much ado, the Technical Expert Group on Patent Law Issues headed by Dr R.A. Mashelkar has resubmitted its report to the Union Ministry of Commerce. Dual mandate And though the report has taken a line similar to the governing law on patentability of new chemical and medical entities, it …
Unveils new range of over-the-counter products Special Correspondent NEW DELHI: Hamdard (Wakf) Laboratories on Tuesday announced its foray into lifestyle wellness space by unveiling the
INDIAN vaccine makers are setting their sights on tapping the growing US market after the Obama Administration committed $300 million for implementing immunisation programmes in the country. Companies like Bharat Biotech, Serum Institute and Biological E, regular suppliers to WHO vaccines programmes, are now looking at entering the US market. …
The president of Islamabad Chamber of Commerce and Industry (ICCI) on Friday said the government should encourage the domestic pharmaceutical industry in order to ensure availability of good quality medicines to the masses at affordable prices. Talking to a delegation of pharmaceutical association at his office, Shaukat Masud said drugs …
GlaxoSmithKline and Pfizer plan to combine their HIV-drug units into a new company that will control almost 20% of the market for treating the deadly virus. London-based Glaxo will hold 85% of the joint venture and Pfizer the remainder, the drugmakers said in a statement on Thursday. The new company …
Civil society groups dejected, mull PIL; setback also for Wockhardt. Joe C Mathew / Bangalore April 17, 2009, 0:14 IST The patent office has upheld the validity of Roche
Hoping to challenge Gilead Sciences, the leader in H.I.V. drugs, the pharmaceutical giants GlaxoSmithKline and Pfizer said Thursday that they would form a specialty company to research, develop and market treatments for H.I.V., the virus that causes AIDS. By combining products from both companies, the new entity would have 11 …
Amended Law Proposes Imprisonment For Officials Of Errant Companies & Scrapping Of Licence THE government plans to amend the Drugs & Cosmetics Act to slap up to 10 years of imprisonment and cancellation of licence for violating norms for testing drugs on humans in India, a government official said.
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has issued directions to enforcement agencies to recover around Rs 116 crore from 31 pharmaceutical firms, including Dr Reddy
